Objectif In OECD countries the most frequent cause of mortality is cardiovascular diseases. Addressing this problem needs a holistic approach, where ICT-based monitoring is in the focus.The disruptive innovation programme sets the target of performing complex mobile invasive monitoring of cardiovascular and associated diseases, of forecasting the state of the patients, supporting the therapy treatments and assessing the effectiveness of drugs on mobile information-technology-base.The devices are miniature holter monitors built into the human body, which with their diagnostic algorithm will regularly or continuously assess and check the physiological condition of the users.Innovation content: 7/24 monitoring, continous data processing, intelligent automated evaluation systems, lifelong mobile crisis management, optimized drug taking protocol, implants with long life.Main ecomic benefits: higher health and life safety, higher economic efficiency as a result of the improvement in people health condition, less patient-doctor appointment, reduced cost of cardiovascular treatment, reduced number of operations.Main target group: patients who have been/will be operated on any cardiovascular disease and people who have high risk factor.The business model is built on the sale of appliances and on the sale of the related subscription-based info-communication service packages. According to the initial financial plan we count with a turnover of 100.000 pieces and an outstanding profit and return by the end of the fifth year after the market launch.We plan the diffusion of the system in three steps with expanding geographical coverage. Before entering the markets we establish dealerships in the regions and develop a regional distributor and technical support system as well.As desired achievements of the phase 1 five main parts of the Feasibility Study will be elaborated: Market Analysis Business Plan, Marketing Plan, Legal and Organisational Plan and Technological Plan. Champ scientifique medical and health scienceshealth scienceshealth care serviceseHealthsocial sciencessociologydemographymortalitysocial scienceseconomics and businessbusiness and managementbusiness modelsmedical and health sciencesclinical medicinecardiologycardiovascular diseasessocial sciencessociologygovernancecrisis management Programme(s) H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) Main Programme H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument Thème(s) ICT-37-2014-1 - Open Disruptive Innovation Scheme (implemented through the SME instrument) Appel à propositions H2020-SMEInst-2014-2015 Voir d’autres projets de cet appel Sous appel H2020-SMEINST-1-2014 Régime de financement SME-1 - SME instrument phase 1 Coordinateur ATRACTOR KUTATASI, FEJLESZTESI ES SZOLGALTATO KFT Contribution nette de l'UE € 50 000,00 Adresse HERMINA UT. 57-59 1146 BUDAPEST Hongrie Voir sur la carte PME L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention. Oui Région Közép-Magyarország Budapest Budapest Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 71 429,00
